Literature DB >> 6313110

Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.

A G Fitton, R G Pertwee.   

Abstract

delta 9-Tetrahydrocannabinol (delta 9-THC) was injected into the preoptic area of the anterior hypothalamus or into the third or fourth cerebral ventricle of the conscious mouse through a chronically implanted cannula and the effects on body temperature and oxygen consumption rate were measured. At an ambient temperature of 22 degrees C, injections of delta 9-THC into the fourth ventricle (5 and 10 microgram) produced dose-dependent falls in rectal temperature. Hypothermia was also observed after injections of the drug into the hypothalamus (5 and 10 microgram) or into the third ventricle (10 microgram). The hypothermia produced by delta 9-THC was associated with a fall in oxygen consumption rate. Falls in rectal temperature and in oxygen consumption rate were significantly greater after injection of delta 9-THC than after injection of the drug vehicle, Tween 80. The falls in rectal temperature and oxygen consumption rate produced by injection of delta 9-THC into the fourth ventricle were abolished by elevation of the ambient temperature from 22 to 32 degrees C. A pretreatment that consisted of subcutaneous injections of delta 9-THC (20 mg/kg) given once daily for three days produced tolerance to the hypothermic effect of the drug when injected on day 4 either into the fourth ventricle (10 microgram) or into a lateral tail vein (2.0 mg/kg). The results suggest that delta 9-THC acts centrally to alter thermoregulation in mice not only when it is injected directly into the hypothalamus or cerebral ventricles but also when it is given intravenously. After intraventricular or intravenous administration the drug may act at extrahypothalamic as well as at hypothalamic sites. The data also support the hypothesis that in mice, tolerance to the hypothermic effect of A9-THC is pharmacodynamic and does not depend on changes in metabolism or distribution of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6313110      PMCID: PMC2071615          DOI: 10.1111/j.1476-5381.1982.tb08802.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice.

Authors:  R G Pertwee; R Tavendale
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

2.  Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.

Authors:  E W Gill; G Jones
Journal:  Biochem Pharmacol       Date:  1972-08-15       Impact factor: 5.858

3.  Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.

Authors:  E W Gill; G Jones; D K Lawrence
Journal:  Biochem Pharmacol       Date:  1973-01-15       Impact factor: 5.858

4.  Preliminary experiments on the chemistry and pharmacology of cannabis.

Authors:  E W Gill; W D Paton; R G Pertwee
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

5.  The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.

Authors:  E W Gill; D K Lawrence
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

6.  Hypothermic effects of intraventricular and intravenous administration of cannabinoids in intact and brainstem transected cats.

Authors:  W T Schmeling; M J Hosko
Journal:  Neuropharmacology       Date:  1980-06       Impact factor: 5.250

7.  The effects of cyclic adenosine 3',5'-monophosphate and other adenine nucleotides on body temperature.

Authors:  M J Dascombe; A S Milton
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

8.  Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

9.  Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region.

Authors:  W T Schmeling; M J Hosko
Journal:  Pharmacol Biochem Behav       Date:  1976-07       Impact factor: 3.533

10.  Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.

Authors:  H D Christensen; R I Freudenthal; J T Gidley; R Rosenfeld; G Boegli; L Testino; D R Brine; C G Pitt; M E Wall
Journal:  Science       Date:  1971-04-09       Impact factor: 47.728

View more
  21 in total

1.  Role of neuronal nitric oxide synthase in the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.

Authors:  Amanda Borgquist; Cecilia Meza; Edward J Wagner
Journal:  J Neurophysiol       Date:  2014-11-12       Impact factor: 2.714

2.  Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone.

Authors:  Simone Macrì; Lara Lanuzza; Gustavo Merola; Chiara Ceci; Stefano Gentili; Antonella Valli; Teodora Macchia; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-01-08       Impact factor: 3.911

3.  The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

Authors:  Alexandre A Steiner; Alla Y Molchanova; M Devrim Dogan; Shreya Patel; Erika Pétervári; Márta Balaskó; Samuel P Wanner; Justin Eales; Daniela L Oliveira; Narender R Gavva; M Camila Almeida; Miklós Székely; Andrej A Romanovsky
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

4.  Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.

Authors:  Charles W Schindler; Benjamin R Gramling; Zuzana Justinova; Eric B Thorndike; Michael H Baumann
Journal:  Drug Alcohol Depend       Date:  2017-08-18       Impact factor: 4.492

5.  CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.

Authors:  Joel E Schlosburg; Scott T O'Neal; Daniel H Conrad; Aron H Lichtman
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

6.  AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion.

Authors:  Adam P Chambers; Henry S Koopmans; Quentin J Pittman; Keith A Sharkey
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

7.  Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol.

Authors:  Matthew J Pava; Emily M Blake; Stephen T Green; Brandon J Mizroch; Patrick J Mulholland; John J Woodward
Journal:  Psychopharmacology (Berl)       Date:  2011-06-24       Impact factor: 4.530

8.  Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.

Authors:  Jérémie Joffre; Che-Chung Yeh; Erika Wong; Mayuri Thete; Fengyun Xu; Ivana Zlatanova; Elliot Lloyd; Lester Kobzik; Matthieu Legrand; Judith Hellman
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

9.  Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.

Authors:  R G Pertwee; L A Stevenson; G Griffin
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 10.  Sex differences in the cannabinoid regulation of energy homeostasis.

Authors:  Borzoo Farhang; Shanna Diaz; Stephanie L Tang; Edward J Wagner
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.